Clinical Trials Directory

Trials / Unknown

UnknownNCT03271268

Cardiovascular Biomarkers and Lung Edema in Severe Burns Patients

The Role of CARdiovascular biOmarkers (NT-pro-BNP and CD146) in Predicting Lung Edema in Severely Burned Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
36 (estimated)
Sponsor
Saint-Louis Hospital, Paris, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Burn injury leads to hypovolemic then distributive shock. Fluid resuscitation remains the cornerstone of initial treatment of burn shock. However, fluid rescucitation can lead to fluid overload, which manifests most notably as lung edema. The peptide NT-pro-BNP, a biomarker of cardiac congestion secreted by the myocardium, as well as plasma CD146, an endothelial factor involved in angiogenesis and a marker of vascular congestion, may help identifying patients with risk of pulmonary edema and hypoxia . Our hypothesis is that these biomarkers may predict the occurence of pulmonary edema in severe burns patients.

Conditions

Timeline

Start date
2017-08-06
Primary completion
2019-02-06
Completion
2019-04-06
First posted
2017-09-05
Last updated
2017-09-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT03271268. Inclusion in this directory is not an endorsement.